Literature DB >> 19200579

Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.

Dolores López-Terrada1, Preethi H Gunaratne, Adekunle M Adesina, Joseph Pulliam, David M Hoang, Yummy Nguyen, Toni-Ann Mistretta, Judith Margolin, Milton J Finegold.   

Abstract

Hepatoblastoma is characterized by a diversity of differentiation patterns, some resembling stages of liver development, and occasionally associated with clinical behavior. Our hypothesis is that histologic microheterogeneity in hepatoblastoma correlates with molecular heterogeneity and reflects different stages of developmental arrest. We studied the activation status of the Wnt and Notch pathways and the differential expression of hepatocyte nuclear factor 4alpha, EGFR, and IGF2 genes, relevant to liver development and malignant transformation in histologic variants of hepatoblastoma. Eighty-seven percent of 32 hepatoblastoma cases studied carried CTNNB1 mutations within the ubiquitination domain. Large deletions were seen only in pure fetal cases, also characterized by CCND1 and GLUL (GS) overexpression. Hepatoblastomas with small-cell type appeared clearly distinct and were the only ones with negative GLUL expression. HES1 expression and HES1/AXIN2 used to measure Notch versus Wnt activation ratio were particularly elevated in pure fetal cases and were lowest in hepatoblastomas with small-cell component. Hepatocyte nuclear factor 4alpha was relatively elevated only in embryonal hepatoblastomas. DLK1, DKK, AXIN2, IGF2, and EGFR were increased in all subtypes. Our results support the hypothesis that hepatoblastoma microheterogeneity correlates with molecular heterogeneity. DLK1, a marker of bipotential oval cells, is consistently up-regulated in hepatoblastoma. Therefore, we speculate that hepatoblastomas may arise from a proliferating bipotential precursor. Wnt activation is prevalent in hepatoblastomas, most significantly in predominantly embryonal and mixed types, whereas Notch activation, needed for cholangiocytic differentiation at a more differentiated state, is highest in pure fetal hepatoblastomas. The relative Wnt versus Notch activation appears useful in stratifying different subtypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200579     DOI: 10.1016/j.humpath.2008.07.022

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  40 in total

1.  A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.

Authors:  Vivekanand Singh; Michelle Manalang; Meenal Singh; Udayan Apte
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-10

Review 2.  Hepatoblastoma: current knowledge and promises from preclinical studies.

Authors:  Diego F Calvisi; Antonio Solinas
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

3.  Regulatory network analysis of genes and microRNAs in human hepatoblastoma.

Authors:  Jimin He; Xiaoxin Guo; Linlin Sun; Ning Wang; Jiwei Bao
Journal:  Oncol Lett       Date:  2016-09-27       Impact factor: 2.967

Review 4.  β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.

Authors:  Satdarshan Pal Monga
Journal:  Gastroenterology       Date:  2015-03-05       Impact factor: 22.682

5.  Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.

Authors:  Marcio H Malogolowkin; Howard M Katzenstein; Rebecka L Meyers; Mark D Krailo; Jon M Rowland; Joel Haas; Milton J Finegold
Journal:  J Clin Oncol       Date:  2011-07-18       Impact factor: 44.544

Review 6.  Current and future management strategies for relapsed or progressive hepatoblastoma.

Authors:  Rajkumar Venkatramani; Wayne L Furman; Joerg Fuchs; Steven W Warmann; Marcio H Malogolowkin
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

7.  Calpain induces N-terminal truncation of β-catenin in normal murine liver development: diagnostic implications in hepatoblastomas.

Authors:  Abigale Lade; Sarangarajan Ranganathan; Jianhua Luo; Satdarshan P S Monga
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

8.  Multi-organ Mapping of Cancer Risk.

Authors:  Liqin Zhu; David Finkelstein; Culian Gao; Lei Shi; Yongdong Wang; Dolores López-Terrada; Kasper Wang; Sarah Utley; Stanley Pounds; Geoffrey Neale; David Ellison; Arzu Onar-Thomas; Richard James Gilbertson
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

9.  MicroRNA expression might predict prognosis of epithelial hepatoblastoma.

Authors:  Mónika Gyugos; Gábor Lendvai; István Kenessey; Krisztina Schlachter; Judit Halász; Péter Nagy; Miklós Garami; Zsuzsa Jakab; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

10.  Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways.

Authors:  Adekunle M Adesina; Dolores Lopez-Terrada; Kwong K Wong; Preethi Gunaratne; Yummy Nguyen; Joseph Pulliam; Judith Margolin; Milton J Finegold
Journal:  Hum Pathol       Date:  2009-02-05       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.